Skip to main content
What types of page to search?

Alternatively use our A-Z index.

Research

Research grants

Gene therapy for G.I. cancer.

SURGICAL RESEARCH SOCIETY (UK)

July 2000 - June 2001

Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy - a double blinded multi-centred trial (PANasta Trial)

CANCER RESEARCH UK (UK)

May 2014 - April 2020

ESPAC 4 Prospective sample collection - ESPAC 4T

CANCER RESEARCH UK (UK)

September 2010 - November 2017

ESPAC-5F Four arm, prospective, multicentre, randomised Phase II trial of immediate surgery compared with neoadjuvant chemotherapies and neoadjuvant chemoradiotherapy

CANCER RESEARCH UK (UK)

July 2013 - December 2019

Stratification of adjuvant chemotherapeutic response to allow personalised choice of pyrimidine prodrug: based on levels of transporters and enzymes involved in initial metabolism

CANCER RESEARCH UK (UK)

November 2013 - April 2017

Protein expression in the pancreatic cancer microenvironment.

ROYAL COLLEGE OF SURGEONS OF ENGLAND(UK)

January 2004 - December 2004

Chemo-resistance in resectable pancreatic cancer

ROYAL COLLEGE OF SURGEONS OF ENGLAND(UK)

February 2009 - January 2010

Evaluation of Lentiviral Vectors for Pancreatic Cancer Gene-Therapy.

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

January 2002 - December 2003

European Study Group for Pancreatic Cancer Trial 5F prospective sample collection - ESPAC-5FT

CANCER RESEARCH UK (UK)

September 2014 - December 2018

European Study Group for Pancreatic Cancer (ESPAC) - Trial 4. Combination versus single agent adjuvant chemotherapy in resectable pancreatic cancer.

CANCER RESEARCH UK (UK)

December 2007 - September 2022

Suitability of lentiviral vectors for pancreatic cancer gene therapy.

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

April 2004 - December 2005

Identification of autoantibodies in pancreatic cancer.

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

April 2003 - March 2006

Identification of autoantibodies in pancreatic cancer using a proteomics approach.

ROYAL COLLEGE OF SURGEONS OF ENGLAND(UK)

October 2003 - September 2004

Liverpool ECMC (LECMC)

CANCER RESEARCH UK (UK), DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

April 2023 - March 2028

ESPAC-4 Completion and ESPAC-5F recurrance project

UNIVERSITY OF HEIDELBERG (GERMANY)

August 2023 - July 2026

Identifying the molecular mechanisms of chemotherapy resistance in pancreatic malignancy

PANCREATIC SOCIETY OF GREAT BRITAIN & IRELAND (UK)

August 2015 - December 2018

Hartmann’s procedure versus intersphincteric abdominoperineal excision: a prospective observational study

BOWEL DISEASE RESEARCH FOUNDATION (BDRF) (UK)

January 2016 - December 2018

Molecular characterisation of the interaction between gemcitabine and capecitabine in the treatment of pancreatic cancer

WELLCOME TRUST (UK)

July 2015 - September 2015

The impact of postoperative Packing of Perianal Abscess Cavities: a multicentre randomised controlled trial (PPAC2)

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

April 2017 - September 2021

CRUK research support for senior research nurse

CANCER RESEARCH UK (UK)

April 2014 - March 2019

MicroRNA profiling in pancreatic stellate cells: validation and assessment of potential to predict response to treatment

PANCREATIC CANCER UK (UK)

March 2015 - March 2016

Cancer Research UK Liverpool Cancer Trials Unit

CANCER RESEARCH UK (UK)

October 2013 - September 2020

Senior Investigators Application

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

April 2011 - March 2019

North West Surgical Trials Centre

CANCER RESEARCH UK (UK)

January 2013 - August 2023

Single Use Negative pRessure dressing for Reduction In Surgical site infection following Emergency laparotomy (SUNRISE)

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

November 2017 - June 2022

Assessing Gas6+ neutrophils in the blood of pancreatic cancer patients undergoing chemotherapy to generate evidence for targeting Gas6/AXL signalling in patients

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST (UK)

September 2023 - August 2025

Research Capability Funding Open Call

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

June 2018 - February 2019

Treatment of unresectable Locally Advanced Pancreas (LAP) cancer with Percutaneous Irreversible Electroporation (PIE) following initial systemic chemotherapy: a feasibility randomised controlled trial (The LAP-PIE) trial

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

February 2020 - February 2025

A risk-adjusted and anatomically stratified cohort comparison study of open surgery, endovascular techniques and medical management for juxtarenal aortic aneurysms. The UK complex aneurysm study (UK-COMPASS).

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

April 2017 - May 2026